InsidersTradesSigma
Total declarations
Companies
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Discover the detailed record of transactions filed by AZAB MOHAMMAD, Director. Insider active across 2 companies, notably Xenon Pharmaceuticals Inc.. Cumulatively, 4 reports have been recorded. Split: 2 buys · 0 sell. Total volume traded: €5k. Activity tracked since 15 December 2021. The latest transaction was disclosed on 24 May 2022 (Acquisition). Regulator: SEC (Form 4). All data is free.
Declarations4 total
5,000 shares@ US$0.392533.6% of flowCommon StockSEC:0001209191-22-031997:0
Ideal exit: 18 Feb 2023 (T+270)
10,000 shares@ US$0.376766.4% of flowCommon StockSEC:0001209191-22-030276:0
Ideal exit: 10 Feb 2023 (T+270)
3,086 shares@ US$3.670.0002% mcap100.0% of flowCommon SharesSEC:0001209191-21-070231
3,086 shares@ US$3.670.0002% mcap50.0% of flowCommon SharesSEC:0001209191-21-070231:0
4 of 4 declarations
About AZAB MOHAMMAD
Mohammad Azab is a Director at Xenon Pharmaceuticals Inc. and Durect Corp, companies specializing in the biopharmaceutical sector. In this role, he participates in the governance of these companies and strategic decision-making. His experience in the sector allows him to provide valuable insights into growth opportunities and market challenges.
